Determination of lamotrigine in human plasma using liquid chromatography-tandem mass spectrometry
- PMID: 30604456
- PMCID: PMC7292279
- DOI: 10.1002/npr2.12045
Determination of lamotrigine in human plasma using liquid chromatography-tandem mass spectrometry
Abstract
Aim: Lamotrigine (LTG) is a widely used anti-epileptic drug that is administered to avoid seizures and to maintain seizure-free status. However, several factors reportedly cause individual differences of plasma LTG levels, and the therapeutic target range of LTG varies between individuals. Thus, to optimize effective doses of LTG, we developed a rapid and simple method for determining plasma LTG concentrations.
Methods: Lamotrigine and the internal standard papaverine were extracted from human plasma using solid-phase extraction. After filtration, 5-μL aliquots of final samples were injected into the liquid chromatography-tandem mass spectrometry instrument and LTG and internal standard were separated using a Cadenza CD-C18 column (100 × 2 mm, 3 μm) with 0.1% formic acid in water/acetonitrile (2/1, v/v).
Results: The calibration curve was linear from 0.2 to 5.0 μg/mL, and assessments of recovery, intra- and inter-day precision and accuracy, matrix effects, freeze and thaw stability, and long-term stability demonstrated good reproducibility. Retention times of LTG and internal standard were 1.6 and 2.0 minutes, respectively, and the total run time was 3.5 minutes for each sample.
Conclusion: We developed a rapid and simple method for determining plasma LTG concentrations. The present novel system could be used to inform LTG dose adjustments for individual patients.
Keywords: epilepsy; lamotrigine; liquid chromatography-tandem mass spectrometry; plasma concentration; solid-phase extraction.
© 2018 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Quantification of lamotrigine in patient plasma using a fast liquid chromatography-tandem mass spectrometry method with backflush technology.Ther Drug Monit. 2015 Apr;37(2):188-97. doi: 10.1097/FTD.0000000000000123. Ther Drug Monit. 2015. PMID: 25162213
-
Simultaneous determination of plasma lamotrigine, lamotrigine N2-glucuronide and lamotrigine N2-oxide by UHPLC-MS/MS in epileptic patients.J Pharm Biomed Anal. 2022 Oct 25;220:115017. doi: 10.1016/j.jpba.2022.115017. Epub 2022 Aug 24. J Pharm Biomed Anal. 2022. PMID: 36030754
-
An easy-to-use liquid chromatography assay for the analysis of lamotrigine in rat plasma and brain samples using microextraction by packed sorbent: Application to a pharmacokinetic study.J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Nov 1;1035:67-75. doi: 10.1016/j.jchromb.2016.09.032. Epub 2016 Sep 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 27697728
-
Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.J Pharm Biomed Anal. 2011 Dec 5;56(4):771-7. doi: 10.1016/j.jpba.2011.07.019. Epub 2011 Jul 23. J Pharm Biomed Anal. 2011. PMID: 21840666
-
Non-invasive therapeutic drug monitoring: LC-MS validation for lamotrigine quantification in dried blood spot and oral fluid/saliva.J Pharm Biomed Anal. 2025 Sep 1;262:116877. doi: 10.1016/j.jpba.2025.116877. Epub 2025 Apr 11. J Pharm Biomed Anal. 2025. PMID: 40239559
Cited by
-
New Method for the Determination of Lamotrigine in Human Saliva Using SPE-LC-DAD.Molecules. 2025 Aug 1;30(15):3237. doi: 10.3390/molecules30153237. Molecules. 2025. PMID: 40807415 Free PMC article.
-
Determination of lamotrigine in human plasma by HPLC-PDA. Application to forensic samples.Forensic Sci Med Pathol. 2025 Mar;21(1):1-10. doi: 10.1007/s12024-024-00812-9. Epub 2024 Apr 10. Forensic Sci Med Pathol. 2025. PMID: 38598081 Free PMC article.
-
Determination of Antiepileptics in Biological Samples-A Review.Molecules. 2024 Oct 2;29(19):4679. doi: 10.3390/molecules29194679. Molecules. 2024. PMID: 39407608 Free PMC article. Review.
References
-
- Froscher W, Keller F, Vogt H, Kramer G. Prospective study on concentration‐efficacy and concentration‐toxicity: correlations with lamotrigine serum levels. Epileptic Disord. 2002;4(1):49–56. - PubMed
-
- Brzakovic BB, Vezmar Kovacevic SD, Vucicevic KM, et al. Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics. J Clin Pharm Ther. 2012;37(6):693–7. - PubMed
-
- Baldoni AO, Freitas‐Lima P, de Santi Ferreira FI, et al. An investigation of the influence of patient‐related factors and comedications on lamotrigine clearance in patients with epilepsy. Clin Exp Pharmacol Physiol. 2016;43(7):685–9. - PubMed
-
- Liu L, Zhao L, Wang Q, Qiu F, Wu X, Ma Y. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 ‐161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Eur J Clin Pharmacol. 2015;71(11):1341–7. - PubMed
-
- Inoue K, Yamamoto Y, Suzuki E, et al. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy. Eur J Clin Pharmacol. 2016;72(5):555–62. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources